Officials in Canada said on 25 February 2021 that Canada's COVID-19 vaccination campaign is ramping up after earlier supply disruptions, Reuters news agency reported on Friday.
Canada's deputy chief public health officer, Howard Njoo, was quoted as telling a briefing that over 240,000 COVID-19 doses were injected last week, the most in more than a month.
"We are seeing positive signs that the rollout is ramping up. ... This is a reflection of greater supply," he said, adding that about 2.9% of Canadians had received at least one dose and this percentage is expected to significantly increase throughout March 2021.
Major General Dany Fortin, in charge of coordinating the COVID-19 vaccine rollout, has said a total of 643,000 doses had been distributed this week, the highest amount yet.
Reportedly, Canada has deals with US pharmaceutical companies Pfizer Inc and Moderna Inc to purchase COVID-19 vaccines, but both companies ran into production problems last month and reduced shipments.
Canada says it is still on track to receive a total of six million doses from Pfizer and Moderna by the end of March 2021 and that anyone who wants a shot can get one by the end of September 2021.
So far, Canada has recorded a total of 21,807 COVID-19 deaths and 855,126 cases.
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine